NT-0249 free base is an orally active NLRP3 inhibitor. NT-0249 has anti-inflammatory activity.
NT-0249 (100 mg/kg, orally, 3 times a day for 28 days) reduces systemic inflammation and astrocyte formation in mice in a pre-established obesity state[1].
References:
[1]. Thornton P, et al. Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796. J Pharmacol Exp Ther. 2024;388(3):813-826. Published 2024 Feb 15.
















